- In May 2024, King Faisal Specialist Hospital and Research Centre (Saudi Arabia) launched a dedicated Rare Bone Disease Clinic, focusing on conditions such as multiple hereditary exostosis. The initiative aims to offer integrated care through genetic counseling, orthopedic intervention, and long-term follow-up, reflecting Saudi Arabia’s growing emphasis on rare disease specialization and early diagnosis in pediatric populations
- In April 2024, Mediclinic Middle East (UAE) entered into a collaboration with an international genomics laboratory to improve access to EXT1 and EXT2 gene mutation testing, streamlining early and accurate diagnosis of MHE. This partnership enhances the capacity of local clinics to deliver precision medicine and underscores the region's push toward personalized healthcare
- In March 2024, Groote Schuur Hospital (South Africa) launched a pilot program integrating MRI-based cartilage cap monitoring for pediatric MHE patients. This initiative is expected to improve surgical planning and long-term orthopedic outcomes, marking a shift toward more proactive and data-driven MHE care in the public health sector
- In February 2024, the Egyptian Ministry of Health rolled out a nationwide awareness campaign on genetic skeletal disorders, including MHE, across public hospitals and pediatric clinics. The campaign focuses on early symptom recognition and referral protocols, aiming to reduce diagnostic delays and improve patient outcomes in underserved regions
- In January 2024, CureRare Africa, a non-profit alliance supporting rare disease management, launched its MHE Registry Pilot in Kenya and Nigeria to track prevalence, treatment pathways, and patient outcomes. This data-driven approach supports clinical research and advocacy efforts, helping bridge care gaps across the continent and fostering collaboration between healthcare providers, researchers, and policymakers
